The global closed system drug transfer device (CSTD) market size was valued at USD 444.3 million in 2020 and is expected to grow at a CAGR of 20.1% during the forecast period. The adoption of these machines has increased owing to growing safety concerns while handling hazardous drugs. Closed system drug transfer devices prevent the transfer of contaminants into the system through the physical barrier or air filtration technology.
Know more about this report: request for sample pages
The increasing number of cancer-related disorders has necessitated the use of these machines to provide enhanced protection to healthcare workers and prevent exposure to potentially hazardous chemicals during the compounding and administration of drugs. These machines are developed to be used throughout the hazardous drug-handling chain and are an integral part of a hazardous drug safety program.
The increasing occurrence of cancer, the introduction of stringent regulations regarding the use of hazardous drugs, and growing investments in the development of advanced healthcare equipment by governments and private organizations are some factors expected to fuel the market demand for closed system drug transfer device during the forecast period.
In January 2018, Baxter International Inc. introduced the Arisure Closed System Transfer Device to enhance its offering in the market. The mechanism is designed for the prevention of entry of contaminants into the intravenous medication delivery system. The machine is also equipped with a closed vial adapter, intravenous dry spike, and a closed male Luer valve to avoid the transfer of hazardous substances out of the system during drug preparation and administration. The machine is developed to be widely used for safer drug preparation, administration and disposal, and minimization of accidental exposure or contamination.
Technological advancements and significant investments in research and development support market growth. New product launches and acquisitions by leading players in the market have increased the demand for closed system drug transfer devices across the globe.
In October 2018, Equashield partnered with Max Care Medical for the distribution of Equashield's closed system transfer mechanism in Saudi Arabia, and other parts of the Middle East & North Africa region. This collaboration was aimed at strengthening Equashield’s geographic presence and leveraging increasing hazardous drug risk awareness in the region. The machine enables a high level of safe handling standards in accordance with USP 800.
The global closed system drug transfer machine market is fueled by increasing demand from countries such as China, Japan, and India, rising healthcare expenditure, and drug approvals. Increasing generation of biohazardous waste, rising safety concerns, and growing need to offer enhanced healthcare services boost the market growth.
Global players are expanding into developing countries to tap market potential, further boosting the market growth. Growing awareness, changing lifestyles, and increasing investment in research and clinical testing would support the growth of the market.
The market is primarily segmented on the basis of type, component, closing mechanism, technology, end-use, and region.
By Closing Mechanism
Know more about this report: request for sample pages
On the basis of type, the market for closed system drug transfer devices is segmented into filtration and barrier. The demand for barrier machines is expected to be high during the forecast period. These machines are equipped with a physical barrier to prevent exchange between the interior of the system and the outside environment. It is designed to prevent the entry of any contaminant or toxic elements inside the system.
The market is segmented into line access, syringe safety, vial access, others, based on components. The vial access segment dominated the global closed system drug transfer machine market in 2020 owing to greater reliability and improved efficiency. The increasing geriatric population, changing lifestyles, and growing occurrence of cancer has increased the demand for these machines.
On the basis of the closing mechanism, the industry is segmented into click-to-lock, luer-lock, push-to-turn, color-to-color, and others. The click-to-lock closed system drug transfer machines are easy to use, safe, and efficient. These systems provide an audible click upon being locked and are designed to reduce repetitive strain injury.
The market is segmented into compartmentalized devices, air filtration devices, diaphragm-based devices, others, based on technology. The diaphragm-based segment dominated the global market for closed system drug transfer device in 2020. These machines are equipped with a diaphragm for the collection of vapors and sprays occurring through equalization of pressure within the system. The adoption of these machines has increased owing to improved safety, easy operation and maintenance, and high efficiency.
The end-use segment has been divided into hospitals, clinics, oncology diagnostic centers, and others. The hospital segment dominated the global market for closed system drug transfer device in 2020. The availability of technologically advanced machines and the presence of medical experts drive the growth of this segment. A large number of cancer cases reported by hospitals coupled with stringent healthcare regulations encourage hospitals to invest in these devices.
North America dominated the global closed system drug transfer device market in 2020. Established healthcare infrastructure, access to healthcare insurance, a rising geriatric population, and technological advancements are some factors fueling the growth in this region.
The presence of leading market players, access to improved healthcare services, rising awareness regarding harmful effects of certain drugs, and increasing occurrence of cancer-related disorders further boosts the growth. Government and private organizations are investing in research & development for the launch of advanced and cost-effective closed system drug transfer mechanisms.
The leading players in the closed system drug transfer device market include Becton Dickinson and Company, JMS Co., Ltd., Codan Medizinische Geräte GmbH & Co Kg, Teva Pharmaceutical Industries Ltd., Victus, Inc., Baxter International Inc., Equashield LLC, B. Braun Melsungen, Caragen Ltd., Yukon Medical, ICU Medical Inc., and Corvida Medical.
These players are expanding their presence across various geographies and entering new markets in developing regions to expand their customer base and strengthen presence in the market. The companies are also introducing new innovative products in the market to cater to the growing consumer demands.